Nanoparticle penetration of human cervicovaginal mucus: The effect of polyvinyl alcohol

• Published in: Journal of controlled release Vol. 192; pp. 202 - 208
• Main Authors: Yang, Ming, Lai, Samuel K., Yu, Tao, Wang, Ying-Ying, Happe, Christina, Zhong, Weixi, Zhang, Michael, Anonuevo, Abraham, Fridley, Colleen, Hung, Amy, Fu, Jie, Hanes, Justin
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 28.10.2014
• Subjects: Adhesiveness; Biodegradable polymers; Cervix Mucus - metabolism; Coated Materials, Biocompatible - chemistry; Coated Materials, Biocompatible - metabolism; Drug Carriers - chemistry; Drug Carriers - metabolism; Drug delivery; Humans; Mucoadhesion; Mucus-penetrating particles; Nanoparticles - chemistry; Nanoparticles - metabolism; Polyesters - chemistry; Polyesters - metabolism; Polyethylene Glycols - chemistry; Polyethylene Glycols - metabolism; Polyglactin 910 - chemistry; Polyglactin 910 - metabolism; Polyvinyl Alcohol - chemistry; Polyvinyl Alcohol - metabolism; Surfactant; Drug delivery; Mucoadhesion; Mucus-penetrating particles; Surfactant; Biodegradable polymers
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2014.07.045

Therapeutic nanoparticles must rapidly penetrate the mucus secretions lining the surfaces of the respiratory, gastrointestinal and cervicovaginal tracts to efficiently reach the underlying tissues. Whereas most polymeric nanoparticles are highly mucoadhesive, we previously discovered that a dense layer of low MW polyethylene glycol (PEG) conferred a sufficiently hydrophilic and uncharged surface to effectively minimize mucin-nanoparticle adhesive interactions, allowing well-coated particles to rapidly diffuse through human mucus. Here, we sought to investigate the influence of surface coating by polyvinyl alcohol (PVA), a relatively hydrophilic and uncharged polymer routinely used as a surfactant to formulate drug carriers, on the transport of nanoparticles in fresh human cervicovaginal mucus. We found that PVA-coated polystyrene (PS) particles were immobilized, with speeds at least 4000-fold lower in mucus than in water, regardless of the PVA molecular weight or incubation concentration tested. Nanoparticles composed of poly(lactide-co-glycolide) (PLGA) or diblock copolymers of PEG-PLGA were similarly immobilized when coated with PVA (slowed 29,000- and 2500-fold, respectively). PVA coatings could not be adequately removed upon washing, and the residual PVA prevented sufficient coating with Pluronic F127 capable of reducing particle mucoadhesion. In contrast to PVA-coated particles, the similar sized PEG-coated formulations were slowed only ~6- to 10-fold in mucus compared to in water. Our results suggest that incorporating PVA in the particle formulation process may lead to the formation of mucoadhesive particles for many nanoparticulate systems. Thus, alternative methods for particle formulation, based on novel surfactants or changes in the formulation process, should be identified and developed in order to produce mucus-penetrating particles for mucosal applications. [Display omitted]